| IBD | Inflammatory bowel disease |
| CD | Crohn’s disease |
| OFG | Orofacial granulomatosis |
| JAK | Janus kinase |
| DTT | Dual-targeted therapy |
| CRP | C-reactive protein |
| GPA | Granulomatosis with polyangiitis |
| IFX | Infliximab |
| IBD | Inflammatory bowel disease |
| CD | Crohn’s disease |
| OFG | Orofacial granulomatosis |
| JAK | Janus kinase |
| DTT | Dual-targeted therapy |
| CRP | C-reactive protein |
| GPA | Granulomatosis with polyangiitis |
| IFX | Infliximab |